MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD.
Cell death
FTLD
Forward programming
MAPT mutation
Mitochondria
ROS
Journal
Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
21
12
2022
accepted:
28
12
2022
pubmed:
5
1
2023
medline:
18
1
2023
entrez:
4
1
2023
Statut:
ppublish
Résumé
Tauopathies are a major type of proteinopathies underlying neurodegenerative diseases. Mutations in the tau-encoding MAPT-gene lead to hereditary cases of frontotemporal lobar degeneration (FTLD)-tau, which span a wide phenotypic and pathological spectrum. Some of these mutations, such as the N279K mutation, result in a shift of the physiological 3R/4R ratio towards the more aggregation prone 4R isoform. Other mutations such as V337M cause a decrease in the in vitro affinity of tau to microtubules and a reduced ability to promote microtubule assembly. Whether both mutations address similar downstream signalling cascades remains unclear but is important for potential rescue strategies. Here, we developed a novel and optimised forward programming protocol for the rapid and highly efficient production of pure cultures of glutamatergic cortical neurons from hiPSCs. We apply this protocol to delineate mechanisms of neurodegeneration in an FTLD-tau hiPSC-model consisting of MAPT
Identifiants
pubmed: 36599286
pii: S2213-2317(22)00369-X
doi: 10.1016/j.redox.2022.102597
pmc: PMC9817175
pii:
doi:
Substances chimiques
Reactive Oxygen Species
0
tau Proteins
0
Protein Isoforms
0
MAPT protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
102597Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest LK: none; AS: A patent application for the optimised forward programming protocol has been filed and submitted. CBS: none. LG: none. TK: none. AE: none. PD: none. MN: none. GS: none. SGM: none. HRS: none. HW: none. SK: none. MP: A patent application for the optimised forward programming protocol has been filed and submitted.